![Hiroshi Nagashima](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hiroshi Nagashima
Directeur Technique/Scientifique/R&D chez PorMedTec Co., Ltd.
Postes actifs de Hiroshi Nagashima
Sociétés | Poste | Début | Fin |
---|---|---|---|
PorMedTec Co., Ltd.
![]() PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Directeur/Membre du Conseil | 01/09/2020 | - |
Directeur Technique/Scientifique/R&D | 01/09/2020 | - |
Historique de carrière de Hiroshi Nagashima
Statistiques
Internationale
Japon | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
PorMedTec Co., Ltd.
![]() PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Health Technology |
- Bourse
- Insiders
- Hiroshi Nagashima
- Expérience